Altitude Investment Management Closes Cannabis Fund I at $30M NYC Based Cannabis Investment Firm Successful Fund I Raise, looks to Fund II NEW YORK––(November 27, 2018) Altitude Investment Management,...
Brandon David of Investing in Cannabis talked with Jon Trauben of Altitude Investments, a venture-capital fund based in New York that invests in early-stage and growth companies in the...
PathogenDx Launches the World’s First Quantitative Microarray Test for Cannabis PDx-QUANT™ is a One-Stop Microbial Testing Solution SCOTTSDALE, Ariz., Oct. 12, 2018 /PRNewswire/ — PathogenDx, Inc., the innovative provider...
Altitude Investment Management Updates Its Cannabis Fund’s Holdings with $23.8 Million in Raised Capital Ten New Investments Since Initial March 2018 Fund Close September 11, 2018 (New York) ––...
DNA-Based Pathogen Testing Company PathogenDx Raises $3.4 Million in Convertible Note Round July 17, 2018 – Tucson, AZ – PathogenDx Corporation, the innovative provider of DNA-based pathogen testing technology...
CannaInsider interviewed Eric Lachance, the COO of Phoenix-based PathogenDx. The company tests cannabis samples for microbial contamination, with its rapid pathogen screening using Raw Sample genotyping (RSG). The company’s...
